Stay updated on Pembrolizumab in 1st Line NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in 1st Line NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab in 1st Line NSCLC Clinical Trial page
- Check4 days agoChange DetectedThe page shows Revision: v3.6.2, replacing the previous Revision: v3.6.0 tag as part of a platform revision update.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now shows a recruitment status note ('No longer looking for participants') and adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) along with an updated Intervention/Treatment section and a Revision: v3.6.0. The previous label 'Intervention / Treatment' has been replaced with 'Intervention/Treatment' and the older 'Revision: v3.5.5' tag was removed.SummaryDifference0.3%

- Check25 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, indicating a minor version update for the page. No substantive content or data changes are reflected in this change set.SummaryDifference0.0%

- Check47 days agoChange DetectedA new publication citation has been added in Publications for the KEYNOTE-189 Japan extension study, with authors and journal details; the entry also indicates a version revision from v3.5.3 to v3.5.4.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page shows an updated revision label 'Revision: v3.5.3' replacing the previous 'Revision: v3.5.2', indicating a software release rather than a change to the study data.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in 1st Line NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in 1st Line NSCLC Clinical Trial page.